Investigation into the Potential Role of Propionibacterium freudenreichii in Prevention of Colorectal Cancer and Its Effects on the Diversity of Gut Microbiota in Rats
Open Access
- 29 April 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (9) , 8080
Abstract
Colorectal cancer (CRC) accounts for 10% of all cancer diagnoses and cancer-related deaths worldwide. Over the past two decades, several studies have demonstrated the clinical benefits of probiotic supplementation and some studies have shown that certain probiotics can modulate immunity and strengthen gut microbiota diversity. This study aims to assess the impact of the Propionibacterium freudenreichii (PF) probiotic against CRC induced by azoxymethane (AOM), and to investigate its effects on gut microbiota diversity in rats, as well as to evaluate the anti-proliferative activities of PF in HCT116 CRC cells. This experiment was performed using four groups of SD rats: normal control, AOM group, PF group (1 × 109 CFU/mL), and standard drug control (5-fluorouracil, 35 mg/kg). Methylene blue staining of colon tissues showed that the administration of PF significantly reduced the formation of colonic aberrant crypt foci (ACF) compared to the AOM control group. In addition, treated rats had lower levels of malondialdehyde in their colon tissue homogenates, indicating that lipid peroxidation was suppressed by PF supplementation. Furthermore, 16S rRNA gene analysis revealed that probiotic treatment enhanced the diversity of gut microbiota in rats. In vitro study showed that the viability of HCT116 cells was inhibited by the probiotic cell-free supernatant with an IC50 value of 13.3 ± 0.133. In conclusion, these results reveal that consuming PF as probiotic supplements modulates gut microbiota, inhibits the carcinogenic effects of AOM, and exerts anti-proliferative activity against CRC cells. Further studies are required to elucidate the role of PF on the immune response during the development and growth of CRC.Keywords
Funding Information
- Universiti Malaya (ST015-2020, CRG/01/02/2020)
- Cyberjaya University (ST015-2020, CRG/01/02/2020)
This publication has 49 references indexed in Scilit:
- Blueberry Husks and Probiotics Attenuate Colorectal Inflammation and Oncogenesis, and Liver Injuries in Rats Exposed to Cycling DSS-TreatmentPLOS ONE, 2012
- Milk Fermented by Propionibacterium freudenreichii Induces Apoptosis of HGT-1 Human Gastric Cancer CellsPLOS ONE, 2012
- New insights into physiology and metabolism of Propionibacterium freudenreichiiInternational Journal of Food Microbiology, 2011
- Microbial Dysbiosis in Colorectal Cancer (CRC) PatientsPLOS ONE, 2011
- A Method for Serial Tissue Processing and Parallel Analysis of Aberrant Crypt Morphology, Mucin Depletion, and Beta-Catenin Staining in an Experimental Model of Colon CarcinogenesisBiological Procedures Online, 2010
- Increased induction of apoptosis by Propionibacterium freudenreichii TL133 in colonic mucosal crypts of human microbiota-associated rats treated with 1,2-dimethylhydrazineBritish Journal of Nutrition, 2008
- Survival and metabolic activity of selected strains ofPropionibacterium freudenreichiiin the gastrointestinal tract of human microbiota-associated ratsBritish Journal of Nutrition, 2007
- Acidic extracellular pH shifts colorectal cancer cell death from apoptosis to necrosis upon exposure to propionate and acetate, major end-products of the human probiotic propionibacteriaApoptosis, 2006
- Survival and beneficial effects of propionibacteria in the human gut: in vivo and in vitro investigationsLe Lait, 2002
- Role of aberrant crypt foci in understanding the pathogenesis of colon cancerCancer Letters, 1995